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INTRODUCTION
Monoclonal gammopathies are hematological disorders characterized by high levels of an immunologically homogeneous immunoglobulin (known as monoclonal protein or M-protein or paraprotein), produced by a rapidly and abnormally proliferating clone of B-lymphocytes and/or plasma cells. [1, 2] They are usually associated with multiple myeloma, monoclonal gammopathy of unknown significance, and Waldenstrom's macroglobulinemia though their presence in other pathologies, namely, cryoglobulinemia, primary amyloidosis, leukemias, lymphomas, etc., has also been described. [1] [2] [3] The M-protein is amenable to detection by serum protein electrophoresis (SPEP) as a single discrete band (M-band), mostly in the γ-globulin region. [1, [3] [4] [5] However, it may sometimes occur in the βor α-globulin regions instead, especially when the M-protein is of IgM or IgA isotype. [3, 4] Rarely, SPEP shows the simultaneous presence of two distinct M-bands (found in 3%-4% of multiple myeloma cases). [1, 3, 6] This condition is termed as "biclonal gammopathy" or "double gammopathy" -an outcome of simultaneous clonal expansions of two different neoplastic cell lines. [1, 3, 6] Recognizing biclonal gammopathies is of interest because assessing both the clonal proteins may help in evaluating the synchronicity of response of the two clones during treatment and follow-up. [1] Besides, double M-bands are frequently associated with other hematological malignancies (viz., leukemias and lymphomas). [6] However, we report an atypical presentation of multiple myeloma which showed double M-bands in SPEP in the absence of true biclonality. We also describe how such situations may be distinguished through inexpensive analytical techniques.
CASE REPORT
A 69-year-old woman who underwent percutaneous transluminal coronary angioplasty (12 months ago) presented with fatigue and generalized weakness on follow-up in a medical college hospital from Meghalaya, northeast India. There This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
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Case Report was considered. Alternatively, as one of the M-bands was present in the β-region, a monoclonal M-protein of IgM or IgA (known for tendency to aggregate) isotype producing a second M-band due to polymeric form was also suspected.
Immunofixation electrophoresis (IFE) was desirable. However, since this facility was not available in Meghalaya, confirmation by IFE was sought in a distant referral diagnostic center. While awaiting the IFE report, we tried to narrow down our suspicion using a simple and inexpensive method of repeating SPEP under reducing conditions (pretreating 100 µL serum with 10 µL of β-mercaptoethanol). The M2-band detected previously in the γ-region was absent in the repeat gel-run. Instead, only a single intense and large M-band in the β-region appeared [ Figure 1c and d]. Therefore, true biclonal gammopathy was ruled out. This was further substantiated by the subsequent IFE report, which detected an IgA-λ monoclonal protein. Two bands were present at different positions that stained positive for only one heavy chain (IgA) and one light chain (lambda) [ Figure 2 ]. In view of the above, the two M-bands in SPEP were attributed to polymeric forms of the same monoclonal protein. Raised serum levels of total IgA (56.5 g/L), lambda light chain (288 mg/L), and β-2-microglobulin (6198 ng/mL) were found on additional workup. The patient was diagnosed as IgA-λ multiple myeloma and started on chemotherapy (bortezomib, lenalidomide, and dexamethasone).
was pallor on general examination. Clinical examination (of the abdomen, chest, cardiovascular and nervous systems) was unremarkable. Her electrocardiography and echocardiography were normal. Bone pain or sternal tenderness was absent.
Routine investigations detected anemia (Hb 83 g/L), leukocytosis (11,500 cells/mm 3 ), and raised erythrocyte sedimentation rate (98 mm/1 st h). Biochemical investigations of the serum revealed increased total protein (9.9 g/dL), diminished albumin (3.2 g/dL), and grossly reversed albumin/globulin ratio. Renal function tests (creatinine 1.1 mg/dL, urea 30 mg/dL) were normal while ionized calcium (1.6 mmol/L) was elevated mildly. Elevations in uric acid (8.2 mg/dL) and lactate dehydrogenase (956 IU/L) were also noted. Ultrasonography of the abdomen showed mild cortical thinning of both kidneys. No osteolytic lesions were found during radiological examination. The patient was admitted for further evaluation.
Bone marrow biopsy showed hypercellular marrow with 40% plasma cells. SPEP was performed in agarose gels (SAS-1 SP-24 kit) in an integrated electrophoresis system (SAS-1plus SAS-2, Helena Biosciences Europe, UK). The gel picture showed two separate M-bands (M1 and M2 in βand γ-globulin regions, respectively, Figure 1a ), producing two distinct M-spikes in the densitometry tracing [ Figure 1b ]. Thus, the possibility of biclonal gammopathy 
DISCUSSION
Multiple myeloma is the second-most common hematological malignancy and accounts for nearly 2% of all cancer deaths. [2] SPEP constitutes an important part of the standard laboratory evaluation for M-protein. [1] [2] [3] [4] [5] However, because of unique biological and physicochemical properties, M-proteins of IgA variety may produce peculiar and atypical patterns during electrophoresis which may pose diagnostic difficulties, namely, more anodal migration (close to the β-region) due to lower isoelectric pH, apparent absence of light chains during IFE due to sequestration of light chain epitopes by the quaternary structure of IgA, and confounding by a fibrinogen band. [1, 3, 7] In our case, two M-bands were observed in a multiple myeloma patient that raised the possibility of biclonal gammopathy. However, this was subsequently ruled out, and the double M-bands were attributed to polymeric forms of a single IgA M-protein. IgA paraproteins tend to aggregate and form polymers. [1, 3] Detecting IgA polymers in multiple myeloma is of clinical relevance because such patients are prone to hyperviscosity syndrome. [8] Further, polymeric IgA can cause anomalous laboratory findings (e.g., spurious hypercalcemia or overestimation of hemoglobin) that may lead to inappropriate treatment decisions. [9, 10] These polymers have a different mobility than the parent monomeric M-protein, thus yielding multiple bands at different positions on SPEP. [1, 3] IFE can be useful in such cases as it has good resolution and provides M-protein isotype information. However, IFE is expensive and still not widely available. Thus, SPEP continues to be the mainstay for M-protein evaluation in many resource-limited settings, [4, 5] like ours. In such situations, the inexpensive method of SPEP after pretreatment with reducing agents (such as β-mercaptoethanol and dithiothreitol) can distinguish true biclonality from polymeric forms. [3] These reductants depolymerize IgA polymers by disrupting disulfide bonds. Multiple bands from IgA polymers are reduced to a single M-spike while the spikes in true biclonal gammopathies are unaffected by this pretreatment, thus facilitating distinction.
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